Search Constraints
Search Results
Select an image to start the slideshow
Streamlined Approach to Identify Novel Immunomodulatory Agents to Mitigate Ischemic Stroke in a Primary Microglia Model
1 of 17
The Impact of Childhood Trauma on the Association Between Inflammation and Negative Symptoms of Schizophrenia
2 of 17
The Immunologic Role of Gm2a and Neuroinflammation
3 of 17
Inflammatory markers are associated with decreased psychomotor speed in patients with schizophrenia
4 of 17
Neuron-specific cellular functions of Interleukin-9 in Alzheimer’s Disease
5 of 17
Innate and Adaptive Immune System Crosstalk in Parkinson's Disease
6 of 17
Gene-Environment Interplay in Parkinson’s Disease Pathogenesis: The Role of Gastrointestinal Inflammation and Regulator of G-protein Signaling 10 in the Gut-Brain Axis
7 of 17
The Interplay Between Inflammation and Kynurenines on Symptoms of Schizophrenia
8 of 17
NOREPINEPHRINE REGULATION OF INFLAMMATORY RESPONSES DURING
MONOCYTE ACTIVATION AND DIFFERENTIATION AND DURING ACUTE STRESS IN
PATIENTS WITH MAJOR DEPRESSION
9 of 17
Diet-Induced Regional and Sex-Dependent Changes in Markers of
Neuroinflammation
10 of 17
Microglial motility under pro-inflammatory conditions in situ:
Relevance to neurodegeneration
11 of 17
CD8 T cell Immunosurveillance of the Polyomavirus-Infected Central Nervous System
12 of 17
Effects of Toxoplasma Serointensity on Cognitive Function
Amongst Schizophrenic Patients
13 of 17
Peripheral cytokine-induced CNS immune activation and effects on mesolimbic dopamine
14 of 17
Relationship between Inflammation and Diurnal Cortisol Secretion in
Patients with Major Depression: Role of Tumor Necrosis Factor Alpha
15 of 17
The Role of Immune Mechanisms in Aging and Neurodegeneration
16 of 17
LRRK2 Function in Immune Cells and Contribution to Parkinson’s Disease
17 of 17